Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Post by Alex1726on Nov 27, 2020 5:05pm
803 Views
Post# 31992762

One day a change must happen.

One day a change must happen.
HAVING a market cap of $49 M and owning a best in class product in a $multi billion  market is a total non sense and  that  can'' t  last  forever. Imagine tfc 1067 would be a drug. This poor manager Howie sould not hire consultant to know how to penetrate the japeneese market for instance , he sould hire a consulting firm to teach him how to unlock the value of SBM technology plateform and that would begin with TFC 1067.

The last announcement with the top 10 pharma could be the beginning of something new  , i say could cos with SBM we never know. Now let"s try for a moment to enter in Geraldine's head.

I suppose, but it is just my thought that this top 10 big Pharma is a European pharma and it is also possible that this Pharma  is not only interested by TFC 1067 but also by other coumpound like the anti-wrinkle and by the hole plateform. We know that the ant-wrinkle and ant-aging project has been supported by government financing.

Maybe , or maybe not Geraldine Deliancourt has been approached by this pharma or maybe she approached this pahrma. If you would be her, would not you try to be partner with a top 10 pharma , wich is probably a French pharma instead of being partner with a moron like Howie.
<< Previous
Bullboard Posts
Next >>